{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:14:17Z","timestamp":1789596857639,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jcf.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T07:21:23Z","timestamp":1425108083000},"page":"594-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3304-8206","authenticated-orcid":false,"given":"Nathalie","family":"Coolen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Chapron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Audureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Veziris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2015.02.006_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1378\/chest.102.1.70","article-title":"Nontuberculous mycobacteria in adult patients with cystic fibrosis","volume":"102","author":"Kilby","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2015.02.006_bb0015","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00006454-199704000-00004","article-title":"Mycobacterial lung disease in cystic fibrosis: a prospective study","volume":"16","author":"Fauroux","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2015.02.006_bb0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200207-679OC","article-title":"Nontuberculous mycobacteria II: nested-cohort study of impact on cystic fibrosis lung disease","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2015.02.006_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/ajrccm.185.2.231","article-title":"Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2015.02.006_bb0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/JCM.39.2.816-819.2001","article-title":"Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis","volume":"39","author":"Sanguinetti","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2015.02.006_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.2005.049247","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","volume":"61","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2015.02.006_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","article-title":"Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis","volume":"9","author":"Esther","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3201\/eid1403.061405","article-title":"Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel","volume":"14","author":"Levy","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jcf.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1183\/09031936.05.00058604","article-title":"Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy","volume":"25","author":"Mussaffi","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2015.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.40.7.1676","article-title":"Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus","volume":"40","author":"Wallace","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2015.02.006_bb0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/JCM.31.4.861-864.1993","article-title":"Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis","volume":"31","author":"Whittier","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2015.02.006_bb0085","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes, approved standard","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.jcf.2015.02.006_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005660","article-title":"Non mycobacterial virulence genes in the genome of the emerging pathogen mycobacterium abscessus","volume":"4","author":"Ripoll","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2015.02.006_bb0095","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI46095","article-title":"Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection","volume":"121","author":"Renna","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2015.02.006_bb0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jcf.2012.01.006","article-title":"Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case\u2013control study","volume":"11","author":"Verregghen","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2015.02.006_bb0105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1183\/09031936.00065612","article-title":"Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients","volume":"41","author":"Catherinot","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2015.02.006_bb0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/rccm.201307-1200OC","article-title":"Epidemiology of nontuberculous mycobacterial infections and associated macrolide use among persons with cystic fibrosis","volume":"188","author":"Binder","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2015.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/bmj.309.6962.1128","article-title":"Matching","volume":"309","author":"Bland","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2015.02.006_bb0120","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jac\/dki146","article-title":"Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing","volume":"55","author":"Foweraker","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcf.2015.02.006_bb0125","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with pseudomonas aeruginosa a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2015.02.006_bb0130","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199315000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199315000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T11:15:37Z","timestamp":1598786137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199315000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1569199315000466"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2015.02.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}